Sarepta Therapeutics
SRPT
SRPT
254 hedge funds and large institutions have $3.03B invested in Sarepta Therapeutics in 2017 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 78 increasing their positions, 91 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.94% more ownership
Funds ownership: 83.52% → 85.46% (+1.9%)
14% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 91
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
254
Holding in Top 10
5
Calls
$325M
Puts
$287M
Top Buyers
| 1 | +$193M | |
| 2 | +$60.5M | |
| 3 | +$31.5M | |
| 4 |
PP
PDT Partners
New York
|
+$31.5M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$26.6M |
Top Sellers
| 1 | -$88.2M | |
| 2 | -$61.2M | |
| 3 | -$59.3M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$33.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$30.6M |